Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
accelerometry
acquired immunodeficiency syndrome
adverse drug reaction
alkylating agents
amphiphysin antibodies
antihistamines
atypical
autoantibodies
autoimmune disease
autonomic dysfunction
autonomic neuropathy
azathioprine
B cell lymphocytes
Barkhof MR criteria for MS
bone marrow suppression
brain atrophy
carcinoma
carcinoma of breast
carcinoma of lung
central nervous system, infection of
cerebellar atrophy, secondary
cerebellar degeneration
cerebral cortex
cerebral cortical atrophy
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, oligoclonal IgG in
cerebrovascular accident, secondary prevention
cladribine
clemastine fumarate
clinicoradiologic dissociation
collapsin response mediator protein 5 IgG
complications
contactin associated protein like 2 antibodies
controversies in neurology
cop 1
cost effectiveness
cyclophosphamide
cyclosporine
dermatomyositis
digital health, wearable technology
disability rating scale, neurological
disability, neurological
disease modifying agents
efficacy
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, paraneoplastic
encephalitis, viral
encephalomyelitis
epidemiology of neurology
evoked potentials
flu-like illness
gadolinium
gait disorder
gammaglobulin therapy, intravenous
ganglionitis
gray matter
herpes virus infection
highly active antiretroviral therapy
human immunodeficiency virus type 1
hypertension
immune reconstitution inflammatory syndrome
immunocompetent
immunologic disease
immunology and the nervous system
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
impotence
infection
interferon
interferon beta 1-a
interferon beta 1-b
JC virus
leucine rich glioma inactivated 1 antibodies
limbic encephalitis
malignancy screen
malignancy, occult
methotrexate
middle cerebellar peduncle
middle cerebellar peduncle, lesion
misdiagnosis
mitoxantrone
monoclonal antibodies
mononeuritis multiplex
motor neuron disease
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, contrast enhanced, delayed
MRI, contrast enhanced, high dose
MRI, demyelinating disease
MRI, diffusion tensor
MRI, diffusion weighted
MRI, false negative
MRI, serial
MRI, volumetry
MRS
multiple sclerosis
multiple sclerosis, benign form of
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, cost of
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, relapsing
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
myasthenia gravis, paraneoplastic
myasthenic syndrome
myelopathy
myelopathy, necrotizing
natalizumab
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic disease, multifocal
neurologic examination
neurologic practice
neuromuscular junction
neuronal cell surface antigen
neuronopathy, sensory
neuropathology
neuropathy
neuropathy, paraneoplastic
neuropathy, peripheral
NMDA antagonists
ocrelizumab
onconeural antibodies
opsoclonus-myoclonus syndrome
paraneoplastic cerebellar degeneration
paraparesis
paraparesis, spastic
peripheral nerve, lesion of
placebo
plasmapheresis
pleocytosis of cerebrospinal fluid
practice guidelines
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
psychological testing
quality of life
ReBUILD study
Red flags
rehabilitation for neurologic disorders
remote effect of cancer on the nervous system
remyelination
renal failure
retinopathy
review article
safety
screening
Sjogren's syndrome
Sjogren's syndrome, neurologic manifestations of
steroid
steroid therapy, CNS treatment and complications with
thrombocytopenia
treatment of neurologic disorder
tumor necrosis factor
viral infection
viral infection, CNS
viral infection, reactivation
visual evoked response
visual loss
wheelchair
white matter disease
white matter, dirty-appearing
workup
xerophthalmia
xerostomia
Showing articles 3450 to 3500 of 6278 << Previous Next >>

Effects of Blood Pressure Lowering on Major Vascular Events Among Patients with Isolated Diastolic Hypertension
Stroke 42:2339-2341, Arima, H.,et al, 2011

Progressive Multifocal Leukoencephalopathy in a Patient without Immunodeficiency
Neurol 77:297-299, Tan, I.L.,et al, 2011

Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging
AJNR 32:984-992, Haldorsen, I.S.,et al, 2011

A Dramatic Case of Intraventricular Cysticercosis
Arch Neurol 6:828-829, Cardenas, G.,et al, 2011

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
Lancet 377:2013-2022, Bousser, M.G.,et al, 2011

Clinicopathologic conference, Neurologic form of immune reconstitution inflammatory syndrome (neuro-IRIS), without evidence of concurrent opportunistic infection
NEJM 362:2343-2352, Case 18-2011, 2011

Microbleeds are Associated with Subsequent Hemorrhagic and Ischemic Stroke in Healthy Elderly Individuals
Stroke 42:1867-1871, Bokura, H.,et al, 2011

Ring Sign on Diffusion-Weighted Imaging
Arch Neurol 68:1474, Finelli, P.F. and Uphoff, D.F., 2011

Presence of Intracranial Artery Calcification Is Associated with Mortality and Vascular Events in Patients with Ischemic Stroke after Hospital Discharge
Stroke 42:3447-3453, Bugnicourt, J.M.,et al, 2011

Resumption of Oral Anticoagulation After Warfarin-Associated Intracerebral Hemorrhage
Stroke 42:3661-3662, 3665, Steiner, T., 2011

Resumption of Oral Anticoagulation After Warfarin-Associated Intracereral Hemorrhage
Stroke 42:3663-3664, 3665, Schulman, S., 2011

Folic Acid Supplements in Pregnancy and Severe Language Delay in Children
JAMA 36:1566-1573, Roth, C.,et al, 2011

Fetal Effects of Anticonvulsant Polytherapies
Arch Neurol 68:1273-1279, Holmes, L.et al, 2011

Extracranial-Intracranial Bypass Surgery for Stroke Prevention in Hemodynamic Cerebral Ischemia
JAMA 306:1983-1992, Powers, W.J.,et al, 2011

Dabigatran Etexilate versus Warfarin in Management of Non-Valvular Atrial Fibrillation in UK Context: Quantitative Benefit-Harm and Economic Analyses
BMJ 343:d6333, Pink, J.,et al, 2011

A New Landscape for Stroke Prevention in Atrial Fibrillation
Stroke 42:3316-3322, Banerjee, A.,et al, 2011

Colors of Fruit and Vegetables and 10-Year Incidence of Stroke
Stroke 42:3190-3195,3001, Oude Griep, L.M.,et al, 2011

Vertebral Artery Dissection Leading to Stroke Caused by Violent Neck Tics of Tourette Syndrome
Neurol 77:1706-1707, Lehman, L.L.,et al, 2011

Differential Features of Carotid and Vertebral Artery Dissections
Neurol 77:1174-1181, Debette, S.,et al, 2011

A Rare Cause of Gait Ataxia
Lancet 378:1274, Rous, C.,et al, 2011

Chronic Heart Failure and Ischemic Stroke
Stroke 42:2977-2982, Haeusler, K.G.,et al, 2011

Responsive Cortical Stimulation for the Treatment of Medically Intractable Partial Epilepsy
Neurol 77:1295-1304,e79, Morrell, M.J.,et al, 2011

Does Therapeutic Hypothermia Affect Time to Awakening in Cardiac Arrest Survivors?
Neurol 77:1346-1350, Fugate, J.E.,et al, 2011

Clinicopathologic Conference, Limbic Encephaitis with Antibodies to Leucine - Rich Glioma - inactivated 1 (LGI 1).
NEJM 365:1825-1833, Case 34-2011, 2011

Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
Arch Neurol 68:1156-1164, Clifford, D.B.,et al, 2011

Encephalitis Associated with Glutamic Acid Decarboxylase Autoantibodies in a Child A Treatable Condition?
Arch Neurol 68:1065-1068, Korff, C.M.,et al, 2011

Rapidly Progressive Alzheimer Disease
Arch Neurol 68:1124-1130, Schmidt, C.,et al, 2011

Treatable Neurological Disorders Misdiagnosed as Creutzfeldt-Jakob Disease
Ann Neurol 70:437-444, Chitravas, N.,et al, 2011

Apixaban versus Warfarin in Patients with Atrial Fibrillation
NEJM 365:981-992,1052, Granger, C.B.,et al, 2011

Hashimotos Encephalopathy
Radiol Case Reports 6:445-449, Ramalho, J. & Castillo, M., 2011

Toxoplasmic Encephalitis IRIS in HIV-Infected Patients
JNNP 82:691-693, Martin-Blondel, G.,et al, 2011

Rapidly Progressive Corticobasal Degeneration Syndrome
Case Rep Neurol 3:185-190, Herrero Valverde, A.,et al, 2011

Herpes Zoster Ophthalmicus-Related Oculomotor Palsy Accompanied by Hutchinson Sign
Neurol 74:e65, Reilly, G.S. & Shin, R.K., 2010

Perioperative Visual Loss in Ocular and Nonocular Surgery
Clin Ophthalmol 4:531-546, Berg, K.T.,et al, 2010

Multiple Ring-Enhancing Lesions of the Brain
J Postgrad Med 56:307-316, Garg, R.K. & Sinha, M.K., 2010

AIDS-Related Lymphomas: Epidemiology, Risk Factors, and Pathobiology
UpToDate, Sept, Kaplan, L.D.,et al, 2010

Ulcerated Plaques in the Aortic Arch Contribute to Symptomatic Multiple Brain Infarction
JNNP 81:1306-1311, Yoshimura,S.,et al, 2010

Recurrent Ischemic Events in Young Adults After First-Ever Ischemic Stroke
Ann Neurol 68:661-671, Putaala,J.,et al, 2010

Tourettes Syndrome
NEJM 363:2332-2338, Kurlan,R., 2010

Cerebral Amyloid Angiopathy
UpToDate: May 2010, Greenberg,S.M.,et al, 2010

Study Design of the CLOSURE I Trial: A Prospective, Multicenter, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System Versus Best Medical Therapy in Patients With Stroke or TIA Due to Presumed Paradoxical Embolism Through a PFO
Stroke 41:2872-2883, Furlan,A.J.,et al, 2010

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
Stroke 41:2108-2129, Morgenstern,L.B.,et al, 2010

Venous Thromboembolic Events After Cerebral Vein Thrombosis
Stroke 41:1901-1906, Miranda,B.,et al, 2010

Atypical Dementia
Lancet 376:656, Cohen-Bittan,J. et al, 2010

Aspirin and Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy
Neurol 75:693-698, Biffi,A.,et al, 2010

Anti-NMDA Receptor Encephalitis Causing Prolonged Nonconvulsive Status Epilepticus
Neurol 75:1480-1482, Johnson,N.,et al, 2010

Effect of Home Testing of International Normalized Ratio on Clinical Events
NEJM 363:1608-1620, Matchar,D.B.,et al, 2010

Prescribing Antiplatelet Medicine and Subsequent Events After Intracerebral Hemorrhage
Stroke 41:2606-2611, Flynn,R.W.V.,et al, 2010

Clinical Features of Facioscapulohumeral Muscular Dystrophy 2
Neurol 75:1548-1554, Greef,J.C.,et al, 2010

Efficacy and Safety of Dabigatran Compared With Warfarin at Different Levels of International Normalised Ratio Control for Stroke Prevention in Atrial Fibrillation: An Analysis of the RE-LY Trial
Lancet 376:975-983, Wallentin,L.,et al, 2010



Showing articles 3450 to 3500 of 6278 << Previous Next >>